Growing community of inventors

Tres Cantos-Madrid, Spain

Rosa Ana García Castro

Average Co-Inventor Count = 5.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 21

Rosa Ana García CastroMaría Gema Fernández Miguel (6 patents)Rosa Ana García CastroDamián García Olmo (6 patents)Rosa Ana García CastroMariano García Arranz (6 patents)Rosa Ana García CastroManuel Ángel González De La Peña (3 patents)Rosa Ana García CastroManuel Angel González De La Peña (2 patents)Rosa Ana García CastroManuel Ángel González De La Pena (1 patent)Rosa Ana García CastroRosa Ana García Castro (6 patents)María Gema Fernández MiguelMaría Gema Fernández Miguel (6 patents)Damián García OlmoDamián García Olmo (6 patents)Mariano García ArranzMariano García Arranz (6 patents)Manuel Ángel González De La PeñaManuel Ángel González De La Peña (3 patents)Manuel Angel González De La PeñaManuel Angel González De La Peña (5 patents)Manuel Ángel González De La PenaManuel Ángel González De La Pena (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universidad Autónoma De Madrid (5 from 30 patents)

2. Tigenix, S.a.u. (4 from 12 patents)

3. Takeda Pharmaceutical Company Limited (2 from 1,178 patents)


6 patents:

1. 11672831 - Use of adipose tissue-derived stromal stem cells in treating fistula

2. 11660318 - Use of adipose tissue-derived stromal stem cells in treating fistula

3. 10780132 - Use of adipose tissue-derived stromal stem cells in treating fistula

4. 10758575 - Use of adipose tissue-derived stromal stem cells in treating fistula

5. 10729726 - Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue

6. 8999709 - Use of adipose tissue-derived stromal stem cells in treating fistula

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/18/2025
Loading…